Jennifer Christian-Herman, Ph.D.
Vice President, Mind Body Medicine and Behavioral Health, Blue Shield of California
Proven, integrated metabolic care built for health plans
Virta delivers lasting weight loss and diabetes reversal at scale while reducing dependence on high-cost medications and lowering total cost of care.
One specialty provider for metabolic health
Virta gives health plans one nationwide clinical model to support a broad range of metabolic needs.
Flexible by design, with or without GLP-1s
Offer weight loss, diabetes care, GLP-1 support, or a combination based on the needs of your population, clients, and benefit strategy.
Evidence-based care
Go beyond participation metrics with clinical outcomes, economic evidence, and real-world results that last.
Human-led, technology-enabled
Provider-led care, coaching, personalized nutrition, and real-time biomarker feedback help members make changes that fit into their daily lives.
Universal clinical impact
Care adapts to culture, budget, and dietary needs, with consistent outcomes across geographies and socioeconomic groups.
Unmatched results that last
Virta delivers measurable health improvements today, with lasting outcomes that help lower the long-term cost of care.
Medication Reduction
59%
Sustained medication reduction alongside improved metabolic health.1
HbA1c Reduction
3.0 pt
Achieved within 90-days, sustained at 1 year2
Weight Loss in 1 Year Without Medication
13%
Clinically meaningful weight loss without weight-loss medication3
Reduction in Heart Attack, Stroke, and Death
56%
Lower incidence of serious downstream cardiometabolic events4
Cost Savings
Up to $6,000
gross savings per member in Year 15
Sustainable Weight Loss
90%
of weight loss sustained at two years without GLP-1s6
With or without GLP-1s, Virta delivers the clinical support members need to lose weight, reverse type 2 diabetes, and lower overall healthcare costs
Learn about our approach to GLP-1s
Seamless implementation
Easy to turn on. Accountable from day one.
Virta is designed for low-friction activation through the health plan ecosystem, with a nationwide provider practice and an outcomes-based commercial model.
Simple to activate
Opt into Virta’s contracted provider practice, licensed in all 50 states.
Integrated billing
Billed as a preventative medical claim or invoiced as an admin fee, with no separate platform fee or surprise PMPM. Members pay $0 to participate.
Aligned to outcomes
Clients pay for engaged members, with performance guarantees that put fees at risk and outcomes tied to clinical and financial impact.
Results you can track
Quarterly reporting shows progress and gives plans visibility into results.
Trusted by 45+ Health Plans & PBMs
While generating significant savings
$1B
Saved in healthcare costs7
45,000
Fewer
doctor visits8
9,600
Hospitalizations
avoided8
Built for every population. Proven for every member.
Virta demonstrates life-changing results for members, irrespective of socioeconomic status, race, or ethnicity.
See Virta's health equity outcomesVirta easily integrates with your business
Virta fits with your existing lines of business to bring the benefits of reversal to your members.
Deliver a transformational clinical solution
Virta’s medical providers complement PCP care, and are licensed to practice in all 50 states.
Address high cost pharmacy spend
Deliver transformative outcomes to the 40% of members with diabetes on high cost drugs.
Scale to your full membership
Virta offers the infrastructure of an enterprise-grade vendor and can support massive, nationwide implementations.
40%
of commercial members with diabetes are on high-cost Rx9
Virta quickly and sustainably reduces the need for prescription medications, and can drastically lower Rx claims from members.
Deliver breakthrough outcomes
Employers are blown away by Virta’s clinical and economic impact, with more than 60% of type 2 diabetes members achieving reversal.
Unlock a new lever for cost savings
Many employers have already tried diabetes management or prevention; reversal is a completely new avenue.
Win and retain more business
Employers agree that Virta represents the next generation of chronic disease management.
60%
of ASO members achieve diabetes reversal10
More than half of ASO patients who are with Virta for one year achieve diabetes reversal—lowering blood glucose below the diabetes threshold while removing all diabetes-specific medications.
A proven solution for the Medicare population
Virta achieves diabetes reversal rates of 60% within the 65+ population11.
Tackle diabetes and related co-morbidities
Virta addresses both direct costs of diabetes as well as related risk factors such as cardiovascular health.
Support members who need it most
Diabetes prevalence in Medicare is 2x the rest of the population, and Medicare patients often lack access to specialty diabetes care.
2x
Diabetes prevalence in Medicare population, compared to entire population12
Medicare patients are particularly hard-hit by the diabetes epidemic. Virta provides a solution to get Medicare patients healthy—and off of expensive prescription medications.
Featured Resources
Frequently asked questions
Want to see what Virta would look like for your population or a client’s?
Fill out this quick form and our team will create an ROI analysis for your population and schedule a review within 5 business days.
Citations and Footnotes
- Hallberg SJ et al. Diabetes Ther. 2018; 9(2): 583-612. Outcomes among one year completers (83% retention in Virta Treatment; 90% retention in Standard Care). Rx refers to the volume of diabetes prescriptions at one year (which excludes metformin) compared to baseline and multiple insulins prescribed to a patient were counted as one Rx.
- Aggregated, de-identified Virta real-world outcomes for members with at least 6 months of data from 2023–2026
- McKenzie AL, Athinarayanan SJ, McCue JJ, Adams RN, Keyes M, McCarter JP, Volek JS, Phinney SD, Hallberg SJ. Type 2 Diabetes Prevention Focused on Normalization of Glycemia: A Two-Year Pilot Study. Nutrients. 2021 Feb 26;13(3):749.
- Roberts CGP, Shanmugam PV, Athinarayanan SJ, Wolfberg AJ, Raskin S, Lopez-Jimenez F. Cardiovascular Outcomes Among Adults with Type 2 Diabetes or Obesity Receiving Carbohydrate-Reduced Nutrition via Telemedicine: A Retrospective Claims-Based Cohort Study. Cardiol Ther. 2026 Oct 2. doi: 10.1007/s40119-026-00478-0.
- Virta Health actuarial analysis based on clinical trial results, published in 2021. Trended 2 years using 6.5% for Medical and 8.8% for Rx. Savings model available upon request.
- Roberts CGP, Athinarayanan SJ, Shetty GK. Two-year weight loss with carbohydrate restriction without GLP-1 RA, across area-deprivation index and gender. Poster presented at: ObesityWeek 2025; November 2–6, 2025; Atlanta, GA. Poster #163.
- Based on aggregated outcomes across Virta’s diabetes reversal and weight loss programs.
- Virta Health (2025). Data Sources & Methodology Supporting the Metabolic Disease Reversal Report. Denver, CO: Virta Health, Inc.
- Commercial health plan partner deployment analysis, n=63,000 eligible T2D population, March 8, 2019
- Hallberg SJ, McKenzie AL, Williams PT, et al.“Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at One Year: An Open-Label, Non-Randomized, Controlled Study.”Diabetes Therapy, 2018; 9(2): 583–612.
- Athinarayanan, S. J., et al. (2021). “Long-term effects of a novel continuous remote care intervention including nutritional ketosis for the management of type 2 diabetes in older adults: a 2-year non-randomized clinical trial.” Cardiovascular Diabetology, 20(1), Article 219.
- Better Medicare Alliance, State of MA, 2024. NORC/Morgan Health Report on Health Disparities in Employer-Sponsored Insurance, 2022.